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Candida parapsilosis is an increasingly important bloodstream pathogen in neonatal intensive
care units (NICU). We investigated a cluster of bloodstream infections in a NICU to determine
whether nosocomial transmission occurred. During a 3-day period, 3 premature infants hospitalized
in the same unit presented with sepsis caused by C. parapsilosis. Electrophoretic karyotype of the
organisms was performed by using pulsed field gel electrophoresis in a countour-clamped
homogeneous electric field system. The isolate from 1 newborn could not be typed, and the isolates
from the remaining 2 infants had identical patterns. All 3 cases are described. We conclude that
nosocomial transmission of C. parapsilosis occurred and that neonates under intensive care may
represent a risk group for this pathogen.
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The relative number of organisms causing nosocomial
bloodstream infections has changed over the last decade,
with Candida species now being firmly established as
one of the most frequent agents worldwide [1, 2]. The
number of nosocomial bloodstream infections due to
Candida species in critically ill neonates is increasing.
Taylor, et al., found that 21% of all cases of candidemia
from a large institution, evaluated during a 7-year
period, were documented in neonatal intensive care
units (NICU) [3].
Nosocomial Candida infections have been
recognized by many investigators as a major cause of
morbidity and mortality in neonatal intensive care units
[4, 5]. Newborns may acquire Candida species
secondary to either vertical or horizontal transmission
[6]. Risk factors identified by multivariate analysis of
NICU populations include prior antibiotic exposure,
hyperalimentation, the use of intravenous fat emulsions,
and endotracheal intubation [7].
In the NICU setting, there are several reports of
Candida albicans nosocomial cross infection [7-17].
However, few studies using molecular DNA-based
typing methods have demonstrated clusters of
hematogenous candidiasis due to non-albicans species
in such a population [15,18-20]. The present report
describes 3 cases of C. parapsilosis candidemia
documented during a 3-day period in a NICU in Rio
de Janeiro, Brazil.
Materials and Methods
Between April 24 and 26, 3 cases of C. parapsilosis
candidemia were documented in a NICU of a 159 bed
private tertiary care hospital in Rio de Janeiro. All clinical
and epidemiological data were retrospectively obtained
by reviewing patients’ clinical charts. In order to
determine the background rate of C. parapsilosis
bloodstream infections, the hospital’s laboratory
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records were reviewed to identify all cases of positive
blood cultures for C. parapsilosis reported from
November 1, 1996, to May 31, 1997.
Cultures. Blood cultures of candidemic patients were
obtained by venipuncture and incubated in a semi-automated
Bactec System. The yeast isolates were identified at the
species level by using the API-20C galleries (BioMerieux).
Susceptibility testing. Yeast profiles of susceptibility to
amphotericin B, fluconazole and 5-flucytosine were
performed by the NCCLS microdilution method [21].
Molecular Typing. In order to investigate the
relatedness among C. parapsilosis isolates, we
performed an electrophoretic karyotype (EK) of the
organisms by using pulsed field gel electrophoresis in
a countour-clamped homogeneous electric field
system (CHEF-DRIII, Richmond-CA), following a
previously described  method  [22, 23].
Briefly, colonies of C. parapsilosis were incubated
overnight in 1% yeast extract, 2% peptone and 2% dextrose.
After centrifugation, the cells were washed with 50 mM
EDTA, pH 8.0 and incubated with lyticase. Agarose blocks
were prepared by adding 1% low melt agarose to this
solution. The blocks were incubated for 12 h in 0.01 M
Tris buffer, 0.45M EDTA, 1% laurylsarcosine and 1mg of
Proteinase K per mL. The washing procedures were
repeated several times the next day and 2 mm of each
agarose block were inserted in individual wells of an 8%
chromosomic grade agarose gel. A countour-clamped
homogeneous electric field was used to separate different
molecular sizes of C. parapsilosis chromosomal DNA.
Saccharomyces cerevisiae chromosome-DNA standard
(BioRad) was inserted into the gel as a standard. In addition,
1 isolate of C. parapsilosis obtained from the blood culture
of an adult patient hospitalized at another institution was
included. The electrophoretic conditions were: 150 volts;
13°C switch time: 120 sec for 24 h and then 240 sec
for 36 h. The gel was stained in ethidium bromide
and phothographed. Two isolates were considered
to have the same electrophoretic karyotype profile if
all of the bands in one isolate matched the bands in
another by visual comparison.
Results
According to data obtained by reviewing the
laboratory records, only 3 cases of candidemia due to
C. parapsilosis were documented in the NICU during
the study period. No other candidemia was detected
during the 6 months prior to the described outbreak
The 3 candidemic patients were put side by side in the
NICU; 2 of the patients were twin sisters.
Case 1 (Second Twin) April, 24. The neonate was
delivered at 28 weeks gestation and weighed 770 g. At
the age of 52 days, she developed a sepsis syndrome
with blood and urine cultures positive for C. parapsilosis.
Prior to fungal infection: Mechanical ventilation and
central venous catheter (CVC) were in place since birth.
Phototherapy, hyperalimentation, and 38 days of
antibiotics were also required.
Outcome: Candida parapsilosis was isolated from
peripheral blood cultures and from the catheter tip that
had been in place since day 34. Amphotericin B was
started on day 54 at 1 mg/kg/day, and the CVC was
removed on day 55. The last positive blood culture
was obtained 3 days after the catheter removal. She
received amphotericin B therapy for 18 days and was
discharged at 136 days of age, 2 months after the end
of treatment, without any sign of infection.
Case 2 (First Twin) April, 26. The neonate was
delivered at 28 weeks gestation and weighed 910 g.
At the age of 54 days, she developed a sepsis syndrome
with blood cultures positive for C. parapsilosis.
Prior to fungal infection: Mechanical ventilation and CVC
were in place for 42 days. Phototherapy, hyperalimentation,
and 38 days of antibiotics were also required. Following
case 1, there was a high suspicion for Candida infection
and amphotericin B at 1 mg/kg/day was started at the very
beginning of clinical signs of sepsis. No CVC had been in
place 12 days prior to the occurrence of fungal sepsis.
Outcome: The patient received amphotericin B
therapy for 18 days, and no additional positive culture
was obtained. She was discharged at 127 days of age,
almost 2 months after the end of treatment, without
any sign of infection.
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Case 3 April 26. The patient was delivered at 27 weeks
gestation and weighed 700 g. At the age of 65 days,
he developed a sepsis syndrome with blood and urine
cultures positive for C. parapsilosis.
Prior to fungal infection: Mechanical ventilation and
CVC were in place since birth. Phototherapy, parenteral
nutrition and 46 days of antibiotics were also required.
Outcome: Amphotericin B was started at 1 mg/kg/day
and the central venous catheter was exchanged.
Additional positive cultures for C. parapsilosis were
obtained from tracheal aspirate on day 67, and blood
cultures on days 69 and 77. Blood cultures remained
positive up to the eleventh day of antifungal therapy,
when the new CVC was removed. After that, all blood
cultures were negative. Amphotericin B was maintained
for a total of 24 days. The fungal infection was cured,
but the patient died at 178 days of age due to
bronchodysplasia complications.
Only 2 of the 3 C. parapsilosis isolates were
available for further susceptibility testing and molecular
typing. The amphotericin B, fluconazole and 5-flucytosine
MIC values for both yeast isolates were 0.5 µg/mL,
0.25 µg/mL and 0.125 µg/mL, respectively. As
illustrated in Figure 1, the electrophoretic karyotype of
the 3 tested isolates exhibited 2 different patterns, one
of them shared by both clinical isolates from the NICU
patients, and the other exhibited by the reference strain.
Discussion
Apart from the increased risk for developing
nosocomial infections, neonates admitted to a NICU are
at an increased risk for infections due to unusual
pathogens [24]. Knowledge of the epidemiology of
nosocomial pathogens documented among newborns
admitted to intensive care units is useful for clinicians to
better treat this population and to anticipate possible
threats. The emergence of Candida species as etiologic
agents of nosocomial infections has been described [6].
In Brazil, recent data obtained from a multicenter study
showed that 28 of 145 (19%) episodes of candidemia
were reported among children admitted to the neonatal
intensive care units of tertiary care hospitals [25].
Although Candida spp can be a perinatal pathogen,
the predominant mode of acquisition in NICU
populations is nosocomial transmission, which is even
more important with C. parapsilosis infections [5, 6].
In Brazil, Levin, et al., have described a cluster of 6
cases of fungemia due to C. parapsilosis among adult
patients [26]. To our knowledge, the present series
represents the first report of a C. parapsilosis outbreak
in a NICU setting described in this country.
The use of liquid glycerin given as a suppository
was identified as a common source of a C. parapsilosis
outbreak in a NICU [19]. In 2 other C. parapsilosis
outbreaks, molecular based studies showed similar
profiles among patients and hands of health care workers
[20, 26]. Unfortunately, in the present report, we were
not able to investigate the common source of the C.
parapsilosis infections. However, the genomic
relatedness of the 2 C. parapsilosis strains, and the
geographic and temporal association are strong
arguments for considering this occurrence a definite
outbreak. We suggest that nosocomial acquisition
through indirect patient contact could have occurred.
Very low birth weight (VLBW - birth weight less
than 1,500 g) infants represent a special risk group of
patients with increased susceptibility for fungal infections
due to their impaired specific and nonspecific defense
mechanisms [27]. Rates of fungal colonization among
VLBW infants are over 20%, Candida albicans and
C. parapsilosis being the most prevalent species; and
7.7% of the colonized patients later develop systemic
Candida infections [8-16, 18-20, 28]. The lower
weight the baby, the higher the risk. In a prospective
study, all infants who developed candidemia, weighed
less than 1,000 g and were previously colonized [29].
In addition to baseline conditions, life saving and
supporting measures such as broad spectrum
antibiotics, mechanical ventilation, parenteral nutrition
and central venous catheters are risk factors for fungal
infection [7, 30, 31]. In our series, all 3 patients weighed
less than 1,000 g at birth and were exposed to these
risk factors previous to the fungal infection.
Among adult patients, systemic infections due to
Candida parapsilosis have been associated with a
lower mortality rate compared to other species of
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Candida 32-34]. This clinical finding is in accordance
with experimental data showing that C. parapsilosis
isolates exhibit a lesser potential for tissue invasion
[35]. In the NICU population, mortality due to C.
parapsilosis may be considerably higher, especially
among the smallest babies [36]. In the largest outbreak
of C. parapsilosis reported among neonates, 21 of
23 babies with systemic infection had a gestational
age of less than 29 weeks, the case-fatality was 39%,
and risk of death was 16-fold greater than that of
controls [18].
The present cases of candidemia were successfully
treated with amphotericin B. As expected, the 2 C.
parapsilosis isolates were very susceptible to all of the
antifungal drugs tested. Of interest, 1 patient continued
to have positive blood cultures despite 11 days of high
dose amphotericin B therapy. The cultures became
negative just after the removal of the CVC catheter.
The issue of removing a central venous catheter in
patients with candidemia is a matter of great
controversy. In a recent report, we described a cohort
of 145 patients with candidemia where catheter
retention was recognized as an independent risk
factor for death [32]. The case mentioned above
illustrates that removing the catheter may influence
clinical outcome.
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